We enrolled patients with a computerised interactive voice response system , and patients were randomly assigned using a permuted block method ( block size of four ) in a @:@ ratio to receive weekly intravenous paclitaxel ( @ mg/m ( @ ) ) plus either weekly masked intravenous placebo or trebananib ( @ mg/kg ) .